The Service of the Commission for the Protection of Competition has received a notification of a concentration concerning the acquisition of the share capital of Mediclinic International Plc by Remgro Limited and SAS Shipping Agencies Services S.à.r.l., via Manta Bidco Limited.
Remgro Limited is a company duly registered under the laws of South Africa. Remgro Limited is a portfolio investment company, holding investments in the healthcare, consumer products, financial services, infrastructure, industrial and media sectors. It mainly focuses on investment management and providing support and not on the day-to-day business management of the companies in which it invests.
SAS Shipping Agencies Services S.à.r.l is a company duly registered under the laws of Luxembourg. It is a subsidiary of MSC Mediterranean Shipping Company Holding S.A., which is the ultimate parent company of the MSC Group. MSC Group is active in maritime transport and logistics, contract logistics and specialized reefer container services as well as rail, inland waterway and road transport. Also, MSC Group’s activities include container handling services in ports and terminal operations and it is also active worldwide in the cruise sector and other marine passenger activities.
Manta Bidco Limited is a company duly registered under the laws of England and Wales. It was established for the purposes of the proposed act, while since its establishment it has not carried out any commercial transactions.
The Target is a company duly registered under the laws of England and Wales. It is an international private healthcare group, headquartered in South Africa with divisions in Switzerland, Southern Africa (South Africa and Namibia) and the Middle East. The main purpose of the Target is to improve the quality of life of its patients by providing comprehensive, high-quality hospital services.